Vanessa Kennedy

10PUBLICATIONS

75CO-AUTHORS

Molecular targetsPredictive and prognostic markersMedical mycologyHaematological tumoursTransplantation immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 01, 2026

Dynamic genetic and nongenetic RAS-pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy.

|Apr 21, 2025

CORAL: Expert-Curated Oncology Reports to Advance Language Model Inference.

Madhumita Sushil, Vanessa E Kennedy, Divneet Mandair

|Sep 12, 2022

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.

Vanessa E Kennedy, Cecelia Perkins, Andreas Reiter

|Aug 26, 2021

Frontline treatment patterns and outcomes among older adults with acute myeloid leukemia: A population-based analysis in the modern era.

Vanessa E Kennedy, Theresa H M Keegan, Qian Li

|Aug 21, 2019

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort.

Michael A Spinner, Vanessa E Kennedy, John S Tamaresis

Pageof 2

Frequent Collaborators

Lori S Muffly

Sally Arai

Samuel Strober

Theresa H M Keegan

Frances B Maguire

Caspian Oliai

Brian A Jonas

Aaron C Logan

Mohamad Jawhar

Johannes Lübke

Frequent Collaborators

Lori S Muffly

Sally Arai

Samuel Strober

Theresa H M Keegan